These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 657590)

  • 21. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumoricidal effector mechanisms of murine Bacillus Calmette-Guérin-activated macrophages: mediation of cytolysis, mitochondrial respiration inhibition, and release of intracellular iron by distinct mechanisms.
    Klostergaard J; Leroux ME; Ezell SM; Kull FC
    Cancer Res; 1987 Apr; 47(8):2014-9. PubMed ID: 3828989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1.
    Nelson BJ; Ralph P; Green SJ; Nacy CA
    J Immunol; 1991 Mar; 146(6):1849-57. PubMed ID: 1900875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible contribution of the complement system to the inflammatory state.
    Hadding U
    Agents Actions Suppl; 1980; 7():24-32. PubMed ID: 7018199
    [No Abstract]   [Full Text] [Related]  

  • 25. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage colony-stimulating factor (M-CSF) enhances complement component C3 production by human monocytes/macrophages.
    Andoh A; Fujiyama Y; Kitoh K; Niwakawa M; Hodohara K; Bamba T; Hosoda S
    Int J Hematol; 1993 Jan; 57(1):53-9. PubMed ID: 8477063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytolytic effects of the complement cleavage product, C3a.
    Ferluga J; Schorlemmer HU; Baptista LC; Allison AC
    Br J Cancer; 1976 Dec; 34(6):626-34. PubMed ID: 827304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of complement cleavage products released from stimulated macrophages in allergic diseases.
    Schorlemmer HU; Hadding U; Bitter-Suermann D
    Monogr Allergy; 1979; 14():218-21. PubMed ID: 503076
    [No Abstract]   [Full Text] [Related]  

  • 29. Ontogeny of 'macrophage' function. IV. Newborn mouse macrophages strongly suppress tumour cell growth and readily acquire cytolytic activity in comparison with adult macrophages.
    Ido M; Uno K; Inaba K; Aotsuka Y; Muramatsu S
    Immunology; 1984 Jun; 52(2):307-17. PubMed ID: 6735438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement C3 cleavage and cytokines interleukin-1beta and tumor necrosis factor-alpha in otitis media with effusion.
    Närkiö-Mäkelä M; Teppo AM; Meri S
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1745-9. PubMed ID: 11037838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    Meltzer MS; Benjamin WR; Farrar JJ
    J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoregulation by macrophages II. Separation of mouse peritoneal macrophages having tumoricidal and bactericidal activities and those secreting PGE and interleukin I.
    Hopper KE; Cahill JM
    J Reticuloendothel Soc; 1983 Jun; 33(6):443-56. PubMed ID: 6602218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolytic stage.
    Varesio L
    J Immunol; 1985 Feb; 134(2):1262-7. PubMed ID: 3965571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A possible self-regulating mechanism mediated by C3b-acceptor-bound C3b generated by stimulated macrophages.
    Fábry Z; Erdei A; Gergely J
    Scand J Immunol; 1985 Nov; 22(5):549-55. PubMed ID: 2934802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inability of the C3a anaphylatoxin to promote cellular lysis.
    Goodman MG; Weigle WO; Hugli TE
    Nature; 1980 Jan; 283(5742):78-80. PubMed ID: 7350527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of complement in the function of the monocyte - macrophage system.
    Schorlemmer HU
    Haematol Blood Transfus; 1981; 27():59-71. PubMed ID: 6976918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of macrophage activation in chronic inflammation.
    Allison AC; Ferluga J; Prydz H; Schorlemmer HU
    Agents Actions; 1978 Jan; 8(1-2):27-35. PubMed ID: 345781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine polymorphonuclear leukocytes synthesize and secrete the third component and factor B of complement.
    Okuda T
    Int Immunol; 1991 Apr; 3(4):293-6. PubMed ID: 1878337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.